We are live on ! Find out more
TDAC

Translational Development Acquisition Corp

Positive
Neutral
Negative
Sentiment 3-Months
Positive 20%
Neutral 80%
Negative 0%

Neutral
GlobeNewsWire
2 days ago
ProLogium and Translational Development Acquisition Corp. Announce $50 Million Committed Primary Capital Investment to Support Proposed Business Combination
TAIPEI, Taiwan and NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- Prologium Holding Inc. (“ProLogium” or the “Company”), a global leader in the innovation and manufacturing of next-generation lithium ceramic batteries, and Translational Development Acquisition Corp. (“TDAC”) (Nasdaq: TDAC), a special purpose acquisition company, today announced that ProLogium and TDAC have secured commitments for a $50 million primary capital investment from a consortium of existing ProLogium shareholders to support the previously announced business combination that would result in ProLogium becoming a publicly listed company (the “Transaction”).
ProLogium and Translational Development Acquisition Corp. Announce $50 Million Committed Primary Capital Investment to Support Proposed Business Combination
Neutral
PRNewsWire
24 days ago
TDAC Announces ProLogium's Filing of F-4 As Continuing Momentum Towards Merger
NEW YORK, July 6, 2026 /PRNewswire/ -- Translational Development Acquisition Company (NYSE: TDAC) ( "TDAC") announced that ProLogium has filed their initial F-4 with the SEC driving the companies forward towards a successful execution of the de-SPAC transaction. This filing gives the SEC and investors at large a fuller view into the history of ProLogium and further supporting information into the merger transaction that was announced on May 27, 2026.
TDAC Announces ProLogium's Filing of F-4 As Continuing Momentum Towards Merger
Neutral
PRNewsWire
1 month ago
TDAC Announces Very Successful Share Redemption Results in Connection with Extension Vote
85% of Shares are not Redeemed, resulting in TDAC maintaining $156.8mm in trust 95% of the Shares Voted Were In Favor of the Extension These Great Results Follow the Momentum of the May 27, 2026 announcement of TDAC's Entry into a Merger Agreement with Prologium Prologium is a global leader in next generation lithium ceramic battery technology, moving into growth markets, including AI Data Centers, aerospace, robotics, defense and electric vehicles NEW YORK, June 22, 2026 /PRNewswire/ -- Translational Development Acquisition Company (NYSE: TDAC) (the "Company" or "TDAC") announced the very successful results of the shareholder vote held on 6/17/26 regarding the proposed extension of the SPAC life and election of shareholders to redeem their shares or continue to participate in TDAC. In connection with the meeting, holders of the Company's Class A common stock were given the opportunity to redeem their shares for a pro-rata portion of the Company's trust account.
TDAC Announces Very Successful Share Redemption Results in Connection with Extension Vote
Positive
Reuters
2 months ago
Battery maker ProLogium to list on Nasdaq in $3.8 billion SPAC deal
Taiwanese battery maker ProLogium Technology will go public in New York through a merger with ​blank-check vehicle Translational Development Acquisition Corp in a $3.8 ‌billion deal, the companies announced on Wednesday.
Battery maker ProLogium to list on Nasdaq in $3.8 billion SPAC deal
Neutral
GlobeNewsWire
2 months ago
ProLogium, a Next Generation Solid-State Battery Developer with 10+ Years of Proven Commercialization, to List on the Nasdaq through a Merger with Translational Development Acquisition Corp.
ProLogium reached commercial-scale manufacturing for solid-state batteries in 2013, later delivered the world's first solid-state battery demo car with ENOVATE Motor in 2019.  ProLogium has shipped a total of over 2.4 million battery cells to customers since 2013, of which more than 800,000 are its 3 rd -generation batteries from the Gigafactory in Taiwan.
ProLogium, a Next Generation Solid-State Battery Developer with 10+ Years of Proven Commercialization, to List on the Nasdaq through a Merger with Translational Development Acquisition Corp.